Consolidated Statements of Operations (Unaudited) - USD ($) $ in Thousands |
3 Months Ended | 6 Months Ended | ||||
|---|---|---|---|---|---|---|
Jun. 30, 2022 |
Jun. 30, 2021 |
Jun. 30, 2022 |
Jun. 30, 2021 |
|||
| Revenue | ||||||
| Service and subscription revenue | $ 84,823 | $ 36,419 | $ 151,969 | $ 67,887 | ||
| Net interest income on loan receivables | 2,517 | 1,761 | 5,085 | 3,423 | ||
| Total revenue, net | 87,340 | 38,180 | 157,054 | 71,310 | ||
| Operating expenses | ||||||
| Provision for credit losses on consumer receivables | 26,981 | 15,698 | 50,025 | 21,406 | ||
| Compensation and benefits | 26,498 | 8,172 | 48,541 | 15,229 | ||
| Marketing | 9,477 | 9,166 | 20,893 | 13,529 | ||
| Direct costs | 29,386 | 10,543 | 50,590 | 20,446 | ||
| Professional services | 6,652 | 4,451 | 13,940 | 8,037 | ||
| Technology-related costs | 5,409 | 2,257 | 9,914 | 4,456 | ||
| Other operating expenses | 9,842 | 1,275 | 20,611 | 2,357 | ||
| Total operating expenses | 114,245 | 51,562 | 214,514 | 85,460 | ||
| Net loss before other (expense) income and income taxes | (26,905) | (13,382) | (57,460) | (14,150) | ||
| Interest expense | (7,584) | (1,849) | (13,758) | (3,320) | ||
| Change in fair value of warrant liability | 2,951 | (17,586) | 6,861 | (48,816) | ||
| Change in fair value of subordinated convertible notes | (9,622) | (49,561) | ||||
| Change in fair value of contingent consideration from mergers and acquisitions | 8,480 | 3,820 | ||||
| Other income (expense) | 9 | 3,243 | (907) | 3,270 | ||
| Net loss before income taxes | (23,049) | (39,196) | (61,444) | (112,577) | ||
| Income tax (benefit) expense | 16 | 17 | (28,401) | 42 | ||
| Net loss | (23,065) | (39,213) | (33,043) | (112,619) | ||
| Net income attributable to redeemable noncontrolling interests | (3,077) | (5,844) | ||||
| Accrual of dividends on preferred stock | (2,176) | (4,985) | (3,204) | (9,827) | ||
| Net loss attributable to common shareholders | $ (25,241) | $ (47,275) | $ (36,247) | $ (128,290) | ||
| Net loss per share, basic and diluted (in Dollars per share) | [1] | $ (0.11) | $ (0.97) | $ (0.16) | $ (2.65) | |
| Weighted average shares used in computing net loss per share, basic and diluted (in Shares) | [1] | 236,313,189 | 48,641,247 | 233,540,639 | 48,496,136 | |
| ||||||
| X | ||||||||||
- Definition The aggregate direct operating costs incurred during the reporting period. No definition available.
|
| X | ||||||||||
- Definition Interest income on loan, net. No definition available.
|
| X | ||||||||||
- Definition Amount of expense related to credit loss from transactions other than loan and lease transactions. No definition available.
|
| X | ||||||||||
- Definition The amount of reversal of previously accrued / (accrued) dividends on redeemable convertible preferred stock. No definition available.
|
| X | ||||||||||
- Definition Amount of increase (decrease) in the fair value of derivatives recognized in the income statement. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of expense for employee benefit and equity-based compensation. No definition available.
|
| X | ||||||||||
- Definition Amount of expense (income) related to adjustment to fair value of warrant liability. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of the cost of borrowed funds accounted for as interest expense. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services. Costs of public relations and corporate promotions are typically considered to be marketing costs. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of Net Income (Loss) attributable to redeemable noncontrolling interest. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The net result for the period of deducting operating expenses from operating revenues. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The total amount of other operating cost and expense items that are associated with the entity's normal revenue producing operation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of income (expense) related to nonoperating activities, classified as other. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations. No definition available.
|
| X | ||||||||||
- Definition A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, including tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value-added and excise. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|